Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D002478:Cells, Cultured; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced / Q000628:therapy*; D008748:Methylcholanthrene; D051379:Mice; D008809:Mice, Inbred C3H; D008937:Mitomycins / Q000494:pharmacology; D009163:Mycobacterium bovis / Q000276:immunology*; D009439:Neuraminidase / Q000494:pharmacology*; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000628:therapy; D013997:Time Factors; D014734:Vibrio cholerae / Q000201:enzymology
D001500:BCG Vaccine; D008937:Mitomycins; D008748:Methylcholanthrene; D009439:Neuraminidase